Impact of selected genetic factors on clopidogrel inactive metabolite level and antiplatelet response in patients after percutaneous coronary intervention

BACKGROUND AND OBJECTIVE: Clopidogrel is frequently used as part of optimal dual antiplatelet therapy in high-bleeding risk patients with the acute coronary syndrome. The concentration of the inactive carboxylic acid metabolite of clopidogrel might be useful to evaluate the response to clopidogrel t...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamiak-Giera, Urszula, Czerkawska, Anna, Olędzki, Szymon, Kurzawski, Mateusz, Safranow, Krzysztof, Jastrzębska, Maria, Gawrońska-Szklarz, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994215/
https://www.ncbi.nlm.nih.gov/pubmed/33270185
http://dx.doi.org/10.1007/s43440-020-00197-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994215/
https://www.ncbi.nlm.nih.gov/pubmed/33270185
http://dx.doi.org/10.1007/s43440-020-00197-w

Ejemplares similares